Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3176 |
|
Actual shortage: | 259 (8%) | |
Anticipated shortage: | 5 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2903 (91%) | |
Discontinuation Reports |
355 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 333 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
143 (4%) |
|
Overdue reports |
33 (12%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-PERINDOPRIL/AMLODIPINE | 14MG 10MG | TABLET | Resolved | 2020-10-07 | 2020-12-30 | 125818 |
APO-TAMSULOSIN CR | 0.4MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-10-07 | 2021-02-23 | 125824 |
APO-ARIPIPRAZOLE | 10MG | TABLET | Resolved | 2020-10-14 | 2020-11-11 | 126234 |
APO-ARIPIPRAZOLE | 10MG | TABLET | Resolved | 2020-10-14 | 2020-11-11 | 126239 |
APO-ARIPIPRAZOLE | 15MG | TABLET | Resolved | 2020-10-14 | 2020-11-11 | 126242 |
APO-ARIPIPRAZOLE | 15MG | TABLET | Resolved | 2020-10-14 | 2020-11-11 | 126245 |
APO-ARIPIPRAZOLE | 20MG | TABLET | Resolved | 2020-10-14 | 2020-11-11 | 126248 |
APO-ARIPIPRAZOLE | 20MG | TABLET | Resolved | 2020-10-14 | 2020-11-11 | 126251 |
APO-ARIPIPRAZOLE | 2MG | TABLET | Resolved | 2020-10-14 | 2020-11-11 | 126254 |
APO-ARIPIPRAZOLE | 10MG | TABLET | Resolved | 2020-10-14 | 2020-11-11 | 126257 |
APO-ARIPIPRAZOLE | 30MG | TABLET | Resolved | 2020-10-14 | 2020-11-11 | 126260 |
APO-ARIPIPRAZOLE | 30MG | TABLET | Resolved | 2020-10-14 | 2020-11-11 | 126263 |
APO-ARIPIPRAZOLE | 5MG | TABLET | Resolved | 2020-10-14 | 2020-11-11 | 126266 |
APO-ARIPIPRAZOLE | 5MG | TABLET | Resolved | 2020-10-14 | 2020-11-11 | 126269 |
APO-CINACALCET | 30MG | TABLET | Resolved | 2020-10-14 | 2020-12-21 | 126274 |
APO-DASATINIB | 100MG | TABLET | Resolved | 2020-10-14 | 2020-11-02 | 126277 |
APO-FLUVOXAMINE | 50MG | TABLET | Resolved | 2020-10-14 | 2020-11-02 | 126280 |
APO-IBUPROFEN | 400MG | TABLET | Resolved | 2020-10-14 | 2021-01-11 | 126283 |
APO-LANSOPRAZOLE | 15MG | CAPSULE (DELAYED RELEASE) | Resolved | 2020-10-14 | 2020-11-09 | 126286 |
APO-LANSOPRAZOLE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2020-10-14 | 2020-11-09 | 126289 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-CEFPROZIL | 250MG | TABLET | Discontinued | 2019-01-04 | 2019-02-21 | 71195 |
ACID CONTROL | Discontinued | 2019-01-04 | 2019-01-04 | 71198 | ||
APO-RABEPRAZOLE | 20MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-01-04 | 2019-01-04 | 71201 |
APO-RABEPRAZOLE | 10MG | TABLET (ENTERIC-COATED) | Discontinued | 2019-01-04 | 2019-01-04 | 71204 |
APO-METFORMIN ER | 500MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2019-01-04 | 2019-01-04 | 71207 |
ACID REDUCER | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71210 |
APO-LOSARTAN | 100MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71213 |
ACETAMINOPHEN TABLETS USP 500 MG | 500MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71216 |
ACETAMINOPHEN TABLETS USP 325 MG | 325MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71219 |
ACETAMINOPHEN CAPLETS 325 MG | 325MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71222 |
ACETAMINOPHEN CAPLETS 500 MG | 500MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71225 |
NAPROXEN SODIUM TABLETS | 220MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71228 |
APO-IRBESARTAN | 75MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71231 |
APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71234 |
APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71237 |
APO-RIZATRIPTAN RPD | Discontinued | 2019-01-04 | 2019-04-04 | 71334 | ||
APO-BOSENTAN | 62.5MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71339 |
APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71342 |
APO-TELMISARTAN | 40MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71345 |
APO-AMITRIPTYLINE | 10MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71348 |